Funding
The Human Immunodeficiency Virus Laboratory has received targeted funding to support Dr. Badley's research.
Grants
| Investigator & Role |
Grant Title |
Funding Source |
Duration |
| Andrew D. Badley, M.D., principal investigator |
Prime shock and kill for HIV erradication (R01AI110173) |
National Institute of Allergy and Infectious Diseases |
02/15/14 - 04/30/24 |
| Andrew D. Badley, M.D., principal investigator |
Evaluating the role of the novel apoptosis inhibitor TRAILshort, in maintaining HIV persistence (R01AI120698) |
National Institute of Allergy and Infectious Diseases |
06/15/15 - 05/31/20 |
| Andrew D. Badley, M.D., principal investigator |
Ixazomib to reduce HIV reservoir size |
amfAR-The Foundation for AIDS Research |
02/06/17 - 01/06/19 |
| Andrew D. Badley, M.D., principal investigator |
Enhancing control of HIV by inhibiting TRAILshort (R56AI102959) |
National Institute of Allergy and Infectious Diseases |
02/06/13 - 01/06/15 |